RAC1 and focal segmental glomerulosclerosis: For example, human gene mutations in Rac1 regulatory proteins, ARHGAP24 and ARGHDIA, have been reported to alter Rac1 activity and are associated with focal segmental glomerulosclerosis [12, 29–31]; more so, recent evidence suggests that these disturbances are implicated in minimal change disease [12].